2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)
复制标题
DOI：
10.1093/eurheartj/ehac237
复制
发表时间：
2022-08-26
影响因子：
39.3
通讯作者：
Wort, Stephen John
中科院分区：
文献类型：
--
作者：
Humbert, Marc;Kovacs, Gabor;Wort, Stephen John
肺动脉高压（PH）是一种病理生理性疾病，可能涉及多种临床状况，并可能与各种心血管和呼吸系统疾病相关。管理PH的复杂性需要多方面，整体和多学科的方法，PH患者与临床医生合作积极参与。在日常临床实践中简化PH患者的护理是有效管理PH的一项具有挑战性但必不可少的要求。近年来，在检测和管理PH方面取得了实质性进展，并及时将新证据整合到第四版ESC/ERS指南中，用于肺动脉高压的诊断和治疗。为了反映多学科对PH患者管理和新证据解释的投入，工作组包括心脏病专家和肺病专家、胸外科医生、方法学家和患者。这些全面的临床实践指南涵盖了PH的整个范围，重点是诊断和治疗肺动脉高压（PAH）和慢性血栓栓塞性肺动脉高压（CTEPH）。
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple clinical conditions and may be associated with a variety of cardiovascular and respiratory diseases. The complexity of managing PH requires a multifaceted, holistic, and multidisciplinary approach, with active involvement of patients with PH in partnership with clinicians. Streamlining the care of patients with PH in daily clinical practice is a challenging but essential requirement for effectively managing PH. In recent years, substantial progress has been made in detecting and managing PH, and new evidence has been timeously integrated in this fourth edition of the ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Reflecting the multidisciplinary input into managing patients with PH and interpreting new evidence, the Task Force included cardiologists and pneumologists, a thoracic surgeon, methodologists, and patients. These comprehensive clinical practice guidelines cover the whole spectrum of PH, with an emphasis on diagnosing and treating pulmonary arterial hypertension (PAH) and chronic thrombo-embolic pulmonary hypertension (CTEPH).